» Articles » PMID: 12580947

Interaction of Actinobacillus Actinomycetemcomitans Outer Membrane Vesicles with HL60 Cells Does Not Require Leukotoxin

Overview
Journal Cell Microbiol
Publisher Wiley
Date 2003 Feb 13
PMID 12580947
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Outer membrane derived vesicles (MVs) secreted by Actinobacillus actinomycetemcomitans JP2 contain a membranolytic leukotoxin and are toxic to human HL60 cells. To determine how MVs interact with human target cells, HL60 cells were incubated with vesicles, reacted with anti-vesicle antibodies and a FITC-labelled reporter, and visualized by confocal scanning laser microscopy. Target cells rapidly became reactive with anti-vesicle antibodies upon exposure to vesicles. Confocal microscopy showed that labelling occurred primarily in the cytoplasmic membrane and that very little internal fluorescence was observed. The cytoplasmic membrane of HL60 cells was also strongly labelled after exposure to MVs that contained the fluorescent phospholipid, SP-DiOC18. In contrast, incubation of cells with free SP-DiOC18 resulted primarily in the labelling of internal structures of HL60 cells. These results suggest that A. actinomycetemcomitans MVs associate with, or are incorporated into the cytoplasmic membrane of HL60 cells. The leukotoxin is a membranolytic cytotoxin and cells exposed to MVs were lysed by vesicle-associated toxin in a time and dose-dependent manner. However, cells became reactive with anti-vesicle antibodies when MVs were added in the presence of inhibitors of leukotoxin-mediated lysis or when sublytic doses of MVs were analysed. In addition, MVs produced by an isogenic leukotoxin-deficient strain of A. actinomycetemcomitans JP2 were non-toxic but rapidly interacted with HL60 cells. These results suggest that A. actinomycetemcomitans MVs can deliver leukotoxin to HL60 cells but that the association of vesicles with the cytoplasmic membrane occurs independently of the leukotoxin polypeptide.

Citing Articles

Heterogeneity of Size and Toxin Distribution in Outer Membrane Vesicles.

Nice J, Collins S, Agro S, Sinani A, Moros S, Pasch L Toxins (Basel). 2024; 16(3).

PMID: 38535804 PMC: 10974469. DOI: 10.3390/toxins16030138.


and : Two exotoxin-producing oral pathogens.

Ozuna H, Snider I, Belibasakis G, Oscarsson J, Johansson A, Uriarte S Front Oral Health. 2022; 3:981343.

PMID: 36046121 PMC: 9420871. DOI: 10.3389/froh.2022.981343.


Applications of Catechins in the Treatment of Bacterial Infections.

Wu M, Brown A Pathogens. 2021; 10(5).

PMID: 34062722 PMC: 8147231. DOI: 10.3390/pathogens10050546.


Epigallocatechin gallate alters leukotoxin secretion and Aggregatibacter actinomycetemcomitans virulence.

Chang E, Brown A J Pharm Pharmacol. 2021; 73(4):505-514.

PMID: 33793838 PMC: 7947220. DOI: 10.1093/jpp/rgaa051.


Aggregatibacter actinomycetemcomitans leukotoxin: From mechanism to targeted anti-toxin therapeutics.

Krueger E, Brown A Mol Oral Microbiol. 2020; 35(3):85-105.

PMID: 32061022 PMC: 7359886. DOI: 10.1111/omi.12284.